Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2011-07-05
2011-07-05
Wen, Sharon (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387100, C530S388100, C435S007400, C435S810000
Reexamination Certificate
active
07973143
ABSTRACT:
Compositions, methods and kits for diagnosing and treating cancer are provided. Therapeutic compositions may comprise agents that modulate the expression or activity of a sphingosine-1-phosphate lyase (SPL). Such compositions may be administered to a mammal afflicted with cancer. Diagnostic methods and kits may employ an agent suitable for detecting alterations in endogenous SPL. Such methods and kits may be used to detect the presence of a cancer or to evaluate the prognosis of a known disease. SPL polypeptides, polynucleotides and antibodies are also provided.
REFERENCES:
patent: 5430169 (1995-07-01), Boumendjel et al.
patent: 6187562 (2001-02-01), Duckworth et al.
patent: 6423527 (2002-07-01), Saba et al.
patent: 6495359 (2002-12-01), Saba et al.
patent: 6569666 (2003-05-01), Saba
patent: 6830881 (2004-12-01), Saba et al.
patent: 6858427 (2005-02-01), Gerritsen et al.
patent: 7041291 (2006-05-01), Saba et al.
patent: 7262044 (2007-08-01), Saba et al.
patent: 7674580 (2010-03-01), Saba et al.
patent: 2003/0054366 (2003-03-01), Schlegel et al.
patent: 2003/0059922 (2003-03-01), Saba et al.
patent: 2003/0175939 (2003-09-01), Saba et al.
patent: 2003/0215805 (2003-11-01), Lillie et al.
patent: 2003/0219782 (2003-11-01), Saba et al.
patent: 2004/0005563 (2004-01-01), Mack et al.
patent: 2004/0029114 (2004-02-01), Mack et al.
patent: 2004/0110197 (2004-06-01), Skinner et al.
patent: 2005/0221346 (2005-10-01), Saba et al.
patent: 2006/0252035 (2006-11-01), Friedman et al.
patent: 2008/0085995 (2008-04-01), Saba et al.
patent: WO 93/19760 (1993-10-01), None
patent: WO 95/21848 (1995-08-01), None
patent: WO 99/16888 (1999-04-01), None
patent: WO 99/38983 (1999-08-01), None
patent: WO 99/61581 (1999-12-01), None
patent: WO 00/70028 (2000-11-01), None
patent: WO 01/31029 (2001-05-01), None
patent: WO 01/42479 (2001-06-01), None
patent: WO 01/49879 (2001-07-01), None
patent: WO 01/85953 (2001-11-01), None
patent: WO 02/27028 (2002-04-01), None
patent: WO 03/062390 (2003-07-01), None
Attwood Science 290: 471-473, 2000.
Skolnick et al. Trends in Biotech. 18: 34-39, 2000.
Lederman et al. Molecular Immunology 28: 1171-1181, 1991.
Li et al. PNAS 77: 3211-3214, 1980.
Houghten et al. New Approaches to Immunization, Vaccines 86, Cold Spring Harbor Laboratory, p. 21-25, 1986.
Adachi-Yamada et al., “De Novo Synthesis of Sphingolipids Is Required for Cell Survival by Down-Regulating c-Jun N-Terminal Kinase inDrosophilaImaginal Discs,”Molecular and Cellular Biology 19(10):7276-7286, Oct. 1999.
Adams et al., GenBank Accession No. AA338781, Apr. 18, 1997, 2 pages.
Amalfitano et al., “Fluorescence in situ hybridization study of aneuploidy of chromosomes 7, 10, X, and Y in primary and secondary glioblastomas,”Cancer Genet Cytogenet 116:6-9, 2000.
Amann et al., “Tightly regulatedtacpromoter vectors useful for the expression of unfused and fused proteins inEscherichia coli,” Gene 69(2):301-315, Sep. 30, 1988.
Bejaoui et al., “SPTLC1 is mutated in hereditary sensory neuropathy, type 1,”Nature Genetics 27(3):261-262, Mar. 2001.
Branden et al., “Prediction, Engineering, and Design of Protein Structures,” Introduction to Protein Structure, Garland Publishing, Inc., New York, p. 247, 1991.
Broun et al., “Catalytic Plasticity of Fatty Acid Modification Enzymes Underlying Chemical Diversity of Plant Lipids,”Science 282:1315-1317, Nov. 13, 1998.
Caligan et al., “A High-Performance Liquid Chromatographic Method to Measure Sphingosine 1-Phosphate and Related Compounds from Sphingosine Kinase Assays and Other Biological Samples,”Analytical Biochemistry 281(1):36-44, May 15, 2000.
Dawkins et al., “Mutations inSPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I,”Nature Genetics 27(3):309-312, Mar. 2001.
Fulton, GenBank Database, Accession No. U51031, Mar. 23, 1996, 5 pages.
Fulton, GenBank Database, Accession No. S70123, May 1996, 1 page.
Fyrst et al., “ThePLB2Gene ofSaccharomyces cerevisiaeConfers Resistance to Lysophophatidylcholine and Encodes a Phospholipase B/Lysophospholipase,”Biochemistry 38(18):5864-5871, May 4, 1999.
Gable et al., “Mutations in the YeastLCB1 and LCB2Genes, Including Those Corresponding to the Hereditary Sensory Neuropathy Type I Mutations, Dominantly Inactivate Serine Palmitoyltransferase,”The Journal of Biological Chemistry 277(12):10194-10200, Mar. 22, 2002.
GenBank Accession No. GI:1855648, Aug. 1997, 2 pages.
Genbank Accession No. GI:5532486, Apr. 20, 1999, 2 pages.
Genbank Accession No. GI:8133099, May 11, 2000, 2 pages.
Gottlieb et al., “TheDPL1Gene Is Involved in Mediating the Response to Nutrient Deprivation inSaccharomyces cerevisiae,” Molecular Cell Biology Research Communications 1(1):66-71, Apr. 1999.
Hannun et al., “Enzymes of Sphingolipid Metabolism: From Modular to Integrative Signaling,”Biochemistry 40(16):4893-4903, Apr. 24, 2001.
Heitman et al., “FK 506-binding protein proline rotamase is a target for the immunosuppressive agent FK 506 inSaccharomyces cerevisiae,” Proc. Natl. Acad. Sci. USA 88:1948-1952, Mar. 1991.
Herr et al., “Splyregulation of sphingolipid signaling molecules is essential forDrosophiladevelopment,”Development 130:2443-2453, 2003.
Hillier et al., GenBank Database, Accession No. T86263, Mar. 1995, 2 pages.
Ikeda et al., “Sphingosine-1-phosphate lyase SPL is an endoplasmic reticulum-resident, integral membrane protein with the pyridoxal 5'-phosphate binding domain exposed to the cytosol,”Biochemical and Biophysical Research Communications 325:338-343, 2004.
Ioannidis, “Replication validity of genetic association studies,”Nature Genetics 29:306-309, 2001.
Kim et al., “Accumulation of Phosphorylated Sphingoid Long Chain Bases Results in Cell Growth Inhibition inSaccharomyces cerevisiae,” Genetics 156:1519-1529, Dec. 2000.
Kohara, GenBank Database, Accession No. D66593, Dec. 13, 1995, 2 pages.
Lanterman et al., “Characterization of sphingosine kinase (SK) activity inSaccharomyces cerevisiaeand isolation of SK-deficient mutants,”Biochem. J. 332:525-531, 1998.
Lucentini et al., “Gene Association Studies Typically Wrong,”The Scientist 18(24), 6 pages, 2004.
Mao et al., “The dihydrosphingosine-1-phosphate phosphatases ofSaccharomyces cerevisiaeare important regulators of cell proliferation and heat stress responses,”Biochem. J. 342:667-675, 1999.
Marra et al., GenBank Database, Accession No. AA107456, Nov. 6, 1996, 2 pages.
Marra et al., GenBank Database, Accession No. AA589412, Sep. 18, 1997, 2 pages.
Marra et al., GenBank Database, Accession No. WO8172, Sep. 5, 1996, 2 pages.
Melendez et al., “Human sphingosine kinase: molecular cloning, functional characterization and tissue distribution,”Gene 251:19-26, 2000.
Mendel et al., “Sphingosine Phosphate Lyase Expression Is Essential for Normal Development inCaenorhabditis elegans,” The Journal of Biological Chemistry 278(25):22341-22349, Jun. 20, 2003.
Olivera et al., “Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens,”Nature 365:557-560, Oct. 7, 1993.
Oskouian et al., “Sphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancer,”PNAS 103(46):17384-17389, 2006.
Pyne et al., “Sphingosine 1-phosphate signaling in mammalian cells,”Biochem J. 349:385-402, 2000.
Pyne et al., “Sphingosine 1-phosphate signalling via the endothelial differentiation gene family of G-protein-coupled receptors,”Pharmacology&Therapeutics 88:115-131, 2000.
Qie et al., “Identification of aSaccaromycesGene,LCB3, Necessary for Incorporation of Exogenous Long Chain Bases into Sphingolipids,”J. Biol. Chem., 272(26):16110-16117, Jun. 27, 1997.
Reiss et al., “Sphingosine-phosphate Lyase Enhanc
Saba Julie D.
Zhou Jianhui
Children's Hospital & Research Center at Oakland
Seed IP Law Group PLLC
Wen Sharon
LandOfFree
Sphingosine-1-phosphate lyase polypeptides, polynucleotides... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sphingosine-1-phosphate lyase polypeptides, polynucleotides..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sphingosine-1-phosphate lyase polypeptides, polynucleotides... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2701995